Synergistic induction of CXCL10 by interferon-gamma and lymphotoxin-alpha in astrocytes: Possible role in cerebral malaria

Cytokine

Volumn 78, Issue , 2016, Pages 79-86

  Bakmiwewa, Supun M ^a   Weiser, Silvia ^a   Grey, Meredith ^a   Heng, Benjamin ^b   Guillemin, Gilles J ^b   Ball, Helen J ^a   Hunt, Nicholas H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Astrocytes; Cerebral malaria; CXCL10; Interferon gamma; Lymphotoxin alpha

Indexed keywords

CYTOKINE RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON RECEPTOR 1; HERPESVIRUS ENTRY MEDIATOR; LYMPHOTOXIN; LYMPHOTOXIN ALPHA RECEPTOR; LYMPHOTOXIN BETA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; CYTOKINE; STAT1 PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN MALARIA; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CXCL10 GENE; CYTOKINE PRODUCTION; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HVEM GENE; IFN GAMMA GENE; IFN GAMMA R1 GENE; IN VITRO STUDY; IN VIVO STUDY; LT BETA R GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TNFR1 GENE; TNFR2 GENE; UPREGULATION; ANIMAL; BRAIN; CELL CULTURE; CELL LINE; DISEASE MODEL; DRUG EFFECTS; GENETICS; GHANA; IMMUNOLOGY; MALARIA, CEREBRAL; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; ASTROCYTES; BRAIN; CELL LINE; CELLS, CULTURED; CHEMOKINE CXCL10; CYTOKINES; DISEASE MODELS, ANIMAL; GHANA; HUMANS; INTERFERON-GAMMA; LYMPHOTOXIN-ALPHA; MALARIA, CEREBRAL; MICE; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84949604316     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.11.024     Document Type: Article

References (54)

1. Molyneux M.E., Taylor T.E., Wirima J.J., Borgsteinj A. Clinical Features and Prognostic Indicators in Paediatric Cerebral Malaria: A Study of 131 Comatose Malawian Children. Q. J. Med. 1989, 71:441-459.
2. Boivin M.J., Bangirana P., Byarugaba J., et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics 2007, 119(2):e360-e366.
3. John C.C., Bangirana P., Byarugaba J., et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics 2008, 122(1):e92-e99.
4. Berendt A.R., Tumer G.D.H., Newbold C.I. Cerebral malaria: the sequestration hypothesis. Parasitol. Today 1994, 10(10):412-414.
5. Clark I.A., Rockett K.A. The cytokine theory of human cerebral malaria. Parasitol. Today 1994, 10(10):410-412.
6. Hunt N.H., Grau G.E. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003, 24(9):491-499.
7. Sanni L.A., Thomas S.R., Tattam B.N., et al. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am. J. Pathol. 1998, 152(2):611-619.
8. Engwerda C.R., Mynott T.L., Sawhney S., De Souza J.B., Bickle Q.D., Kaye P.M. Locally up-regulated lymphotoxin α, not systemic tumor necrosis factor α, is the principle mediator of murine cerebral malaria. J. Exp. Med. 2002, 195(10):1371-1377.
9. Hunt N.H., Ball H.J., Hansen A.M., et al. Cerebral malaria: gamma-interferon redux. Front. Cell. Infect. Microbiol. 2014, 4:113.
10. Grau G.E., Heremans H., Piguet P.F., et al. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 1989, 86(14):5572-5574.
11. Rhodes-Feuillette A., Bellosguardo M., Druilhe P., et al. The interferon compartment of the immune response in human malaria: II. Presence of serum-interferon gamma following the acute attack. J. Interferon Res. 1985, 5(1):169-178.
12. Day N.P.J., Hien T.T., Schollaardt T., et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 1999, 180(4):1288-1297.
13. Koch O., Awomoyi A., Usen S., et al. IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. J. Infect. Dis. 2002, 185(11):1684-1687.
14. Upadhyay V., Fu Y.-X. Lymphotoxin signalling in immune homeostasis and the control of microorganisms. Nat. Rev. Immunol. 2013, 13(4):270-279.
15. Mauri D.N., Ebner R., Montgomery R.I., et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity 1998, 8(1):21-30.
16. Crowe P.D., VanArsdale T.L., Walter B.N., et al. A lymphotoxin-beta-specific receptor. Science 1994, 264(5159):707-710.
17. De Togni P., Goellner J., Ruddle N.H., et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994, 264(5159):703-707.
18. Pasparakis M., Alexopoulou L., Grell M., Pfizenmaier K., Bluethmann H., Kollias G. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci. 1997, 94(12):6319-6323.
19. Grau G., Fajardo L., Piguet P., Allet B., Lambert P., Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987, 237(4819):1210-1212.
20. Shaffer N., Grau G.E., Hedberg K., et al. Tumor necrosis factor and severe malaria. J. Infect. Dis. 1991, 163(1):96-101.
21. van Hensbroek M.B., Palmer A., Onyiorah E., et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J. Infect. Dis. 1996, 174(5):1091-1097.
22. Togbe D., Loureiro de Sousa P., Fauconnier M., et al. Both functional LTβ receptor and TNF receptor 2 Are required for the development of experimental cerebral malaria. PLoS ONE 2008, 3(7):e2608.
23. Miu J., Mitchell A.J., Müller M., et al. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J. Immunol. 2008, 180(2):1217-1230.
24. + T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 2003, 170(4):2221-2228.
25. Nie C.Q., Bernard N.J., Norman M.U., et al. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog. 2009, 5(4):e1000369.
26. + T cell migration to the brain by IFN-γ during experimental cerebral malaria. Parasite Immunol. 2008, 30(10):544-553.
27. Campanella G.S.V., Tager A.M., El Khoury J.K., et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. 2008, 105(12):4814-4819.
28. Armah H.B., Wilson N.O., Sarfo B.Y., et al. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malaria J. 2007, 6:147.
29. Takano T., Oberheim N., Cotrina M.L., Nedergaard M. Astrocytes and ischemic injury. Stroke; J. Cereb. Circ. 2009, 40(3 Suppl.):S8-S12.
30. Medana I.M., Chaudhri G., Chan-Ling T., Hunt N.H. Central nervous system in cerebral malaria: /'Innocent bystander/' or active participant in the induction of immunopathology?. Immunol. Cell. Biol. 2001, 79(2):101-120.
31. Combes V., Guillemin G.J., Chan-Ling T., Hunt N.H., Grau G.E.R. The crossroads of neuroinflammation in infectious diseases: endothelial cells and astrocytes. Trends Parasitol. 2012, 28(8):311-319.
32. Medana I.M., Hunt N.H. Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood-retinal barrier. Glia 1996, 16(1):51-64.
33. Deininger M.H., Kremsner P.G., Meyermann R., Schluesener H.J. Focal accumulation of cyclooxygenase-1 (COX-1) and COX-2 expressing cells in cerebral malaria. J. Neuroimmunol. 2000, 106(1-2):198-205.
34. Croitoru-Lamoury J., Guillemin G.J., Boussin F.D., et al. Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNFα and IFNγ in CXCR4 and CCR5 modulation. Glia 2003, 41(4):354-370.
35. Guillemin G.J., Kerr S.J., Smythe G.A., et al. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J. Neurochem. 2001, 78(4):842-853.
36. Alliot F., Pessac B. Astrocytic cell clones derived from established cultures of 8-day postnatal mouse cerebella. Brain Res. 1984, 306(1-2):283-291.
37. Dalton D., Pitts-Meek S., Keshav S., Figari I., Bradley A., Stewart T. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993, 259(5102):1739-1742.
38. Potter S., Chan-Ling T., Ball H.J., et al. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int. J. Parasitol. 2006, 36(4):485-496.
39. Walther M., Woodruff J., Edele F., et al. Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J. Immunol. 2006, 177(8):5736-5745.
40. McCall M.B.B., Sauerwein R.W. Interferon-γ-central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J. Leukoc. Biol. 2010, 88(6):1131-1143.
41. Howland S.W., Poh C.M., Gun S.Y., et al. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Molec. Med. 2013, 5(7):984-999.
42. Deininger M.H., Kremsner P.G., Meyermann R., Schluesener H.J. Differential cellular accumulation of transforming growth factor-β1, -β2, and -β3 in brains of patients who died with cerebral malaria. J. Infect. Dis. 2000, 181(6):2111-2115.
43. Bhowmick S., Duseja R., Das S., Appaiahgiri M.B., Vrati S., Basu A. Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis. Neurosci. Lett. 2007, 414(1):45-50.
44. Van Heteren J.T., Rozenberg F., Aronica E., Troost D., Lebon P., Kuijpers T.W. Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in aicardi-Goutières syndrome. Glia 2008, 56(5):568-578.
45. Pandita R., Pocsik E., Aggarwal B.B. Interferon-γ induces cell surface expression for both types of tumor necrosis factor receptors. FEBS Lett. 1992, 312(1):87-90.
46. Kost E.R., Mutch D.G., Herzog T.J. Interferon-γ and tumor necrosis factor-α induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors. Gynecol. Oncol. 1999, 72(3):392-401.
47. Stoelcker B., Hehlgans T., Weigl K., Bluethmann H., Grau G.E., Männel D.N. Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria. Infect. Immun. 2002, 70(10):5857-5859.
48. Mackenzie C., Grau G., Cart R., Liomba N., Molyneux M., Taylor T. Intravascular leukocytes in the brain in Malawian children with fatal malaria. Am. J. Trop. Med. Hyg. 1999, 61:781.
49. Trendelenburg G., Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 2005, 50(4):307-320.
50. Zhao Y., Rempe D.A. Targeting astrocytes for stroke therapy. Neurotherapeutics 2010, 7(4):439-451.
51. White N., Looareesuwan S., Phillips R., Warrell D., Chanthavanich P., Pongpaew P. Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria. The Lancet 1985, 325(8432):776-778.
52. Sanni L.A., Rae C., Maitland A., Stocker R., Hunt N.H. Is ischemia involved in the pathogenesis of murine cerebral malaria?. Am. J. Pathol. 2001, 159(3):1105-1112.
53. Hempel C., Combes V., Hunt N.H., Kurtzhals J.A.L., Grau G.E.R. CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin. Am. J. Pathol. 2011, 179(4):1939-1950.
54. Penet M.-F., Viola A., Confort-Gouny S., et al. Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J. Neurosci. 2005, 25(32):7352-7358.